4/23/24 16:35 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | DO | P,CMO | M.d | 0 | 0.00 | 0 | 16 | 114 | 31 | D | | | | | | | | | | | | | | |
5/1/23 17:54 | 4/28/23 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | DO | P,CMO | M.d | 0 | 0.00 | 0 | 3 | 16 | 18 | D | | | | | | | | | | | | | | |
4/24/23 16:14 | 4/21/23 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | DO | P,CMO | M.d | 0 | 0.00 | 0 | 16 | | 15 | D | | | | | | | | | | | | | | |
4/29/22 16:43 | 4/28/22 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | DO | P,CMO | M.d | 0 | 0.00 | 0 | 3 | | 2 | D | | | | | | | | | | | | | | |
8/19/21 17:09 | 8/17/21 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | DO | P,CMO | M.d | 0 | 0.00 | 0 | 0 | 44 | 0 | D | | | | | | | | | | | | | | |
8/19/20 16:25 | 8/18/20 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 0 | 0 | 64 | 0 | D | | | | | | | | | | | | | | |
8/15/19 17:15 | 8/13/18 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 0 | 1 | 96 | 3 | D | | | | | | | | | | | | | | |
1/17/19 17:32 | 1/15/19 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 0 | 0 | 2 | 2 | D | | | | | | | | | | | | | | |
8/15/18 16:55 | 8/13/18 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 0 | 1 | 459 | 2 | D | | | | | | | | | | | | | | |
6/14/17 16:30 | 6/12/17 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 0 | 5 | 6 | 88 | D | | | | | | | | | | | | | | |
1/12/17 11:48 | 1/10/17 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 1 | 10 | 14 | 84 | D | -74 | -28 | -40 | 37 | 16 | 28 | 18 | -16 | 8 | -5 | -2 | -27 | | |
6/15/16 17:52 | 6/13/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 1 | 5 | 7 | 77 | D | -68 | -61 | -8 | 30 | 6 | 11 | -10 | 7 | -3 | -3 | -9 | -49 | -50 | |
6/15/16 17:52 | 6/13/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | S.d | -1 | 1.03 | 1 | -1 | -2 | 77 | D | -68 | -61 | -8 | 30 | 6 | 11 | -10 | 7 | -3 | -3 | -9 | -49 | -50 | |
3/16/16 18:31 | 3/14/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 0 | 12 | 20 | 74 | D | -93 | -64 | -67 | -29 | 34 | 32 | 11 | 6 | -4 | -6 | 1 | 31 | -36 | -38 |
3/16/16 18:31 | 3/15/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | S.d | -3 | 0.8300 | 0 | -3 | -4 | 74 | D | -93 | -64 | -67 | -29 | 34 | 32 | 11 | 6 | -4 | -6 | 1 | 31 | -36 | -38 |
6/16/15 15:08 | 6/12/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 2 | 5 | 8 | 65 | D | -72 | -18 | 18 | 19 | 38 | 28 | 10 | -1 | -3 | 1 | -10 | -9 | -58 | -61 |
6/16/15 15:08 | 6/12/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | S.d | -4 | 2.69 | 2 | -1 | -2 | 65 | D | -72 | -18 | 18 | 19 | 38 | 28 | 10 | -1 | -3 | 1 | -10 | -9 | -58 | -61 |
5/21/15 18:29 | 5/19/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 0 | 8 | 14 | 61 | D | -82 | -50 | -14 | -16 | -18 | -6 | 6 | -3 | -2 | 14 | 45 | 48 | 24 | -52 |
5/21/15 18:29 | 5/20/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | S.d | -4 | 1.88 | 0 | -2 | -3 | 61 | D | -82 | -50 | -14 | -16 | -18 | -6 | 6 | -3 | -2 | 14 | 45 | 48 | 24 | -52 |
1/30/15 18:44 | 1/27/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 1 | 13 | 32 | 56 | D | -85 | -80 | -34 | -8 | -10 | -12 | -11 | -4 | 2 | -1 | 20 | 0 | 61 | -67 |
9/19/14 15:38 | 9/17/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 1 | 5 | 12 | 47 | D | -79 | -68 | -76 | -15 | -5 | -9 | -5 | -2 | -7 | -8 | -27 | -26 | -23 | -3 |
8/14/14 18:11 | 8/12/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 0 | 20 | 86 | 43 | D | -77 | -65 | -72 | -17 | -9 | 3 | 12 | 5 | 0 | -3 | -5 | -35 | -36 | -4 |
8/14/14 18:11 | 8/13/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | S.d | -18 | 3.17 | 0 | -6 | -12 | 43 | D | -77 | -65 | -72 | -17 | -9 | 3 | 12 | 5 | 0 | -3 | -5 | -35 | -36 | -4 |
3/18/14 19:23 | 3/14/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 4 | 4 | 18 | 29 | D | -21 | 1 | 35 | 53 | 16 | 9 | 0 | -5 | -1 | -1 | -23 | -76 | -80 | -86 |
3/18/14 19:23 | 3/17/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | S.d | -15 | 12.25 | 4 | -1 | -4 | 29 | D | -21 | 1 | 35 | 53 | 16 | 9 | 0 | -5 | -1 | -1 | -23 | -76 | -80 | -86 |
10/7/13 15:26 | 8/19/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | S.a | -12 | 8.68 | 1 | -1 | -5 | 26 | D | -2 | -38 | -14 | -8 | -3 | -3 | -1 | -2 | -1 | -1 | -22 | 3 | 10 | -73 |
10/7/13 15:23 | 3/12/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | S.a | -6 | 11.90 | 1 | -1 | -2 | 23 | D | -2 | -38 | -14 | -8 | -3 | -3 | -1 | -2 | -1 | -1 | -22 | 3 | 10 | -73 |
8/15/13 18:03 | 8/13/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 1 | 5 | 22 | 26 | D | -21 | -36 | -23 | -9 | -1 | -8 | -5 | -1 | 0 | -1 | 3 | -19 | 31 | -61 |
3/14/13 17:07 | 3/12/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 0 | 0.00 | 1 | 2 | 9 | 23 | D | -21 | -23 | -12 | -6 | -9 | 0 | -3 | -1 | 0 | -4 | -14 | -19 | -25 | 1 |
8/17/11 18:45 | 8/16/11 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 46 | 4.11 | 1 | 11 | 112 | 21 | D | -58 | -15 | -25 | -24 | -30 | -17 | 3 | 2 | -5 | 0 | -11 | 6 | 22 | 24 |
8/8/11 14:33 | 8/5/11 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | O | EVP,CMO | M.d | 41 | 4.11 | 1 | 10 | New | 10 | D | -60 | -23 | -29 | -26 | -34 | -27 | -20 | -15 | -11 | -1 | -8 | 1 | 31 | 25 |
7/14/05 20:08 | 7/12/05 | CRXA | Corixa Corp | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Cindy | WA | O | SVP,Clin | M.d | 395 | 3.95 | 0 | 100 | | 0 | D | | | | | | | | | | | | | | |